| UniProt ID | F263_HUMAN | |
|---|---|---|
| UniProt AC | Q16875 | |
| Protein Name | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | |
| Gene Name | PFKFB3 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 520 | |
| Subcellular Localization | ||
| Protein Description | Synthesis and degradation of fructose 2,6-bisphosphate.. | |
| Protein Sequence | MPLELTQSRVQKIWVPVDHRPSLPRSCGPKLTNSPTVIVMVGLPARGKTYISKKLTRYLNWIGVPTKVFNVGEYRREAVKQYSSYNFFRPDNEEAMKVRKQCALAALRDVKSYLAKEGGQIAVFDATNTTRERRHMILHFAKENDFKAFFIESVCDDPTVVASNIMEVKISSPDYKDCNSAEAMDDFMKRISCYEASYQPLDPDKCDRDLSLIKVIDVGRRFLVNRVQDHIQSRIVYYLMNIHVQPRTIYLCRHGENEHNLQGRIGGDSGLSSRGKKFASALSKFVEEQNLKDLRVWTSQLKSTIQTAEALRLPYEQWKALNEIDAGVCEELTYEEIRDTYPEEYALREQDKYYYRYPTGESYQDLVQRLEPVIMELERQENVLVICHQAVLRCLLAYFLDKSAEEMPYLKCPLHTVLKLTPVAYGCRVESIYLNVESVCTHRERSEDAKKGPNPLMRRNSVTPLASPEPTKKPRINSFEEHVASTSAALPSCLPPEVPTQLPGQNMKGSRSSADSSRKH | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 6 | Phosphorylation | --MPLELTQSRVQKI --CCCCCCHHHCEEE | 18.34 | 20068231 | |
| 12 | Ubiquitination | LTQSRVQKIWVPVDH CCHHHCEEEEEECCC | 35.36 | - | |
| 22 | Phosphorylation | VPVDHRPSLPRSCGP EECCCCCCCCCCCCC | 51.46 | 28102081 | |
| 31 (in isoform 4) | Phosphorylation | - | 6.53 | 22985185 | |
| 36 | Phosphorylation | PKLTNSPTVIVMVGL CCCCCCCEEEEEEEC | 23.76 | 22210691 | |
| 82 | Phosphorylation | RREAVKQYSSYNFFR HHHHHHHHHCCCCCC | 8.21 | 24043423 | |
| 83 | Phosphorylation | REAVKQYSSYNFFRP HHHHHHHHCCCCCCC | 24.69 | 24043423 | |
| 84 | Phosphorylation | EAVKQYSSYNFFRPD HHHHHHHCCCCCCCC | 21.11 | 24043423 | |
| 85 | Phosphorylation | AVKQYSSYNFFRPDN HHHHHHCCCCCCCCC | 15.28 | 24043423 | |
| 97 | Ubiquitination | PDNEEAMKVRKQCAL CCCHHHHHHHHHHHH | 46.03 | - | |
| 100 | Malonylation | EEAMKVRKQCALAAL HHHHHHHHHHHHHHH | 53.36 | 26320211 | |
| 100 | Ubiquitination | EEAMKVRKQCALAAL HHHHHHHHHHHHHHH | 53.36 | - | |
| 111 | Ubiquitination | LAALRDVKSYLAKEG HHHHHHHHHHHHHCC | 37.36 | 21890473 | |
| 111 (in isoform 1) | Ubiquitination | - | 37.36 | 21890473 | |
| 111 (in isoform 2) | Ubiquitination | - | 37.36 | 21890473 | |
| 111 | Ubiquitination | LAALRDVKSYLAKEG HHHHHHHHHHHHHCC | 37.36 | 21906983 | |
| 116 (in isoform 2) | Ubiquitination | - | 55.06 | - | |
| 116 | Ubiquitination | DVKSYLAKEGGQIAV HHHHHHHHCCCEEEE | 55.06 | - | |
| 125 | Ubiquitination | GGQIAVFDATNTTRE CCEEEEEECCCCHHH | 45.98 | - | |
| 130 | Ubiquitination | VFDATNTTRERRHMI EEECCCCHHHHHHHH | 32.38 | - | |
| 171 | O-linked_Glycosylation | NIMEVKISSPDYKDC CEEEEEECCCCCCCC | 30.05 | 32830957 | |
| 172 | Phosphorylation | IMEVKISSPDYKDCN EEEEEECCCCCCCCC | 25.84 | 21712546 | |
| 172 | O-linked_Glycosylation | IMEVKISSPDYKDCN EEEEEECCCCCCCCC | 25.84 | 32830957 | |
| 176 | Ubiquitination | KISSPDYKDCNSAEA EECCCCCCCCCCHHH | 64.28 | - | |
| 189 | Ubiquitination | EAMDDFMKRISCYEA HHHHHHHHHHCHHHH | 46.72 | - | |
| 194 | Phosphorylation | FMKRISCYEASYQPL HHHHHCHHHHCCCCC | 14.03 | 30387612 | |
| 205 | Ubiquitination | YQPLDPDKCDRDLSL CCCCCHHHCCCCCCE | 43.34 | - | |
| 211 | Phosphorylation | DKCDRDLSLIKVIDV HHCCCCCCEEEEEEC | 32.13 | 24719451 | |
| 214 (in isoform 1) | Ubiquitination | - | 38.13 | 21890473 | |
| 214 (in isoform 2) | Ubiquitination | - | 38.13 | 21890473 | |
| 214 | Ubiquitination | DRDLSLIKVIDVGRR CCCCCEEEEEECCHH | 38.13 | 21906983 | |
| 228 | Ubiquitination | RFLVNRVQDHIQSRI HHHHHHHHHHHHHHH | 33.07 | - | |
| 269 | Phosphorylation | QGRIGGDSGLSSRGK CCCCCCCCCCCHHHH | 44.93 | - | |
| 273 | Phosphorylation | GGDSGLSSRGKKFAS CCCCCCCHHHHHHHH | 50.52 | 18452278 | |
| 277 | Ubiquitination | GLSSRGKKFASALSK CCCHHHHHHHHHHHH | 49.32 | - | |
| 280 | Phosphorylation | SRGKKFASALSKFVE HHHHHHHHHHHHHHH | 32.64 | 21406692 | |
| 282 | Ubiquitination | GKKFASALSKFVEEQ HHHHHHHHHHHHHHC | 5.46 | 21890473 | |
| 283 | Phosphorylation | KKFASALSKFVEEQN HHHHHHHHHHHHHCC | 24.62 | 21406692 | |
| 284 | Ubiquitination | KFASALSKFVEEQNL HHHHHHHHHHHHCCH | 55.04 | - | |
| 292 (in isoform 1) | Ubiquitination | - | 63.37 | 21890473 | |
| 292 | Ubiquitination | FVEEQNLKDLRVWTS HHHHCCHHHHHHHHH | 63.37 | 21906983 | |
| 292 (in isoform 2) | Ubiquitination | - | 63.37 | 21890473 | |
| 302 (in isoform 1) | Ubiquitination | - | 37.61 | 21890473 | |
| 302 | Ubiquitination | RVWTSQLKSTIQTAE HHHHHHHHHHHHHHH | 37.61 | 22053931 | |
| 302 (in isoform 2) | Ubiquitination | - | 37.61 | 21890473 | |
| 302 | Ubiquitination | RVWTSQLKSTIQTAE HHHHHHHHHHHHHHH | 37.61 | 21890473 | |
| 306 | Ubiquitination | SQLKSTIQTAEALRL HHHHHHHHHHHHHCC | 34.44 | 21890473 | |
| 319 | Ubiquitination | RLPYEQWKALNEIDA CCCHHHHHHHHHCCC | 42.57 | - | |
| 352 | Ubiquitination | YALREQDKYYYRYPT HHCCCCCCCEECCCC | 34.54 | - | |
| 353 | Phosphorylation | ALREQDKYYYRYPTG HCCCCCCCEECCCCC | 17.64 | 24043423 | |
| 354 | Phosphorylation | LREQDKYYYRYPTGE CCCCCCCEECCCCCC | 6.29 | 24043423 | |
| 355 | Phosphorylation | REQDKYYYRYPTGES CCCCCCEECCCCCCC | 10.69 | 24043423 | |
| 357 | Phosphorylation | QDKYYYRYPTGESYQ CCCCEECCCCCCCHH | 6.77 | 24043423 | |
| 359 | Phosphorylation | KYYYRYPTGESYQDL CCEECCCCCCCHHHH | 44.65 | 24043423 | |
| 362 | Phosphorylation | YRYPTGESYQDLVQR ECCCCCCCHHHHHHH | 29.46 | 24043423 | |
| 363 | Phosphorylation | RYPTGESYQDLVQRL CCCCCCCHHHHHHHH | 11.18 | 24043423 | |
| 366 | Ubiquitination | TGESYQDLVQRLEPV CCCCHHHHHHHHHHH | 1.77 | - | |
| 403 | Phosphorylation | LAYFLDKSAEEMPYL HHHHHCCCHHHCCCC | 40.35 | 20068231 | |
| 411 | Acetylation | AEEMPYLKCPLHTVL HHHCCCCCCCHHHHH | 28.15 | 25953088 | |
| 411 | Ubiquitination | AEEMPYLKCPLHTVL HHHCCCCCCCHHHHH | 28.15 | - | |
| 446 | Phosphorylation | VCTHRERSEDAKKGP HHCCHHHCHHHHCCC | 34.77 | 28348404 | |
| 461 | Phosphorylation | NPLMRRNSVTPLASP CCCCCCCCCCCCCCC | 26.09 | 29255136 | |
| 463 | Phosphorylation | LMRRNSVTPLASPEP CCCCCCCCCCCCCCC | 16.65 | 29255136 | |
| 467 | Phosphorylation | NSVTPLASPEPTKKP CCCCCCCCCCCCCCC | 37.16 | 29255136 | |
| 471 | Phosphorylation | PLASPEPTKKPRINS CCCCCCCCCCCCCCC | 50.46 | 29255136 | |
| 478 | Phosphorylation | TKKPRINSFEEHVAS CCCCCCCCHHHHHHH | 31.50 | 28450419 | |
| 485 | Phosphorylation | SFEEHVASTSAALPS CHHHHHHHHCCCCCC | 23.08 | 28450419 | |
| 486 | Phosphorylation | FEEHVASTSAALPSC HHHHHHHHCCCCCCC | 16.79 | 28450419 | |
| 487 | Phosphorylation | EEHVASTSAALPSCL HHHHHHHCCCCCCCC | 14.73 | 28450419 | |
| 492 | Phosphorylation | STSAALPSCLPPEVP HHCCCCCCCCCCCCC | 29.18 | 22210691 | |
| 500 | Phosphorylation | CLPPEVPTQLPGQNM CCCCCCCCCCCCCCC | 48.16 | 22210691 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 269 | S | Phosphorylation | Kinase | IKBKB | O14920 | GPS |
| 461 | S | Phosphorylation | Kinase | AMPK | Q9Y478 | Uniprot |
| 461 | S | Phosphorylation | Kinase | AMPKA1 | Q13131 | PSP |
| 461 | S | Phosphorylation | Kinase | PRKAA1 | P54645 | GPS |
| 461 | S | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
| 461 | S | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
| 461 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
| 461 | S | Phosphorylation | Kinase | MAPKAPK2 | P49137 | PSP |
| 461 | S | Phosphorylation | Kinase | AMPK-FAMILY | - | GPS |
| 461 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
| 461 | S | Phosphorylation | Kinase | PKC-FAMILY | - | GPS |
| 461 | S | Phosphorylation | Kinase | AMPK_GROUP | - | PhosphoELM |
| 463 | T | Phosphorylation | Kinase | CDK6 | Q00534 | PSP |
| 467 | S | Phosphorylation | Kinase | CDK6 | Q00534 | PSP |
| 471 | T | Phosphorylation | Kinase | PKC | - | Uniprot |
| - | K | Ubiquitination | E3 ubiquitin ligase | BTRC | Q9Y297 | PMID:24658274 |
| - | K | Ubiquitination | E3 ubiquitin ligase | FZR1 | Q9UM11 | PMID:20080744 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of F263_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of F263_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| F264_HUMAN | PFKFB4 | physical | 28514442 | |
| F262_HUMAN | PFKFB2 | physical | 28514442 | |
| CLU_HUMAN | CLUH | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-461 AND SER-467, ANDMASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-461; THR-463 ANDSER-467, AND MASS SPECTROMETRY. | |
| "The stimulation of glycolysis by hypoxia in activated monocytes ismediated by AMP-activated protein kinase and inducible 6-phosphofructo-2-kinase."; Marsin A.S., Bouzin C., Bertrand L., Hue L.; J. Biol. Chem. 277:30778-30783(2002). Cited for: PHOSPHORYLATION AT SER-461. | |